Genetic determinants of mycobacterial susceptibility and pathogenesis

Lead Research Organisation: King's College London
Department Name: Craniofacial Dev Orthodon and Microbiol

Abstract

When bacteria enter a host, such as a person or other animal, they are typically detected by the immune system of the host. The immune response then attempts to kill the invading bacteria. In most cases the immune response is successful. In some cases, though, the immune response fails to kill the invader, and the invading bacteria can become established and grow in the host. When this happens, disease is the result. In many diseases, including tuberculosis, the immune response is not shut off by the bacteria; instead, it is active, but ineffective at killing the invader. In these cases, most of the damage caused by the disease is not caused by the bacteria directly; rather, the damage is caused by this ineffective immune response. The goal of this proposal is to understand how disease-causing bacteria can escape the immune response and become established in the host, and how immune responses, which are supposed to just kill invaders, can instead come to cause so much damage to the host. In order to examine these issues, we developed a new system for the study of infection. In this system, a bacterium called Mycobacterium marinum, which is closely related to the bacterium that causes tuberculosis, is injected into a fruit-fly (Drosophila melanogaster). This system is very useful because much of the immune response to bacteria is similar between flies and higher animals, such as humans or cattle. At the same time, we know a great deal about flies, and have excellent tools for working with them, so that we can easily find flies with mutations that make them more- or less-efficient at fighting this infection, or mutations that make the infection less damaging to the fly. Using these techniques, we can find genes that are important for fighting infections or that cause the damage due to the immune response. These genes are difficult to find in higher organisms, such as mice, because the process is very time-consuming and involves many animals. For example, in order to do the experiments in this proposal in mice would take more than ten years and more than 10,000 mice. The fly allows us to study these genes rapidly and cheaply, without the ethical issues inherent in the use of mice or other mammals.

Technical Summary

My laboratory is interested in the mechanisms by which hosts affect the course of bacterial infections. This includes immune effects, both in terms of eradicating the pathogen and in terms of causing unintended damage to the host. To address these issues, I developed a model system in which Drosophila melanogaster is infected with the broad-spectrum pathogen Mycobacterium marinum, a close relative of the M. tuberculosis complex. This system allows us to find host genes that contribute to the biology of infection in a rapid and unbiased way without using vertebrate animals. I propose to continue and expand a genetic screen I began as a post-doc. The initial screen was for Drosophila mutants that died more quickly or more slowly after M. marinum infection. This screen will be continued and coupled with a second screen for mutants that are unable to fight a non-pathogenic mycobacterial species, M. smegmatis. By screening all mutants for susceptibility to both bacteria we can find genes that contribute to bacterial pathogenesis, help the host kill mycobacteria, or are circumvented by pathogens in order to cause disease. This work has three specific aims: Aim 1. Continuation and expansion of the already-begun genetic screen. We will screen at least 5000 mutant Drosophila lines for changes in time-to-death when infected with M. marinum and susceptibility to M. smegmatis. Aim 2. Secondary screens and basic characterization of many mutants. All mutants from the primary screen will be subjected to a battery of secondary screens to help us organize them into functional classes. Aim 3. Deeper characterization of at least one specific mutant. At least one mutant will be characterized in detail. This work is important and exciting because it affords us an unbiased view of what host processes are important to disease susceptibility and the progress of pathogenesis, important questions that are difficult to answer using more conventional infection models.
 
Description 1. We identified 35 new Drosophila genes with effects on susceptibility to mycobacterial disease. These genes encode proteins in many different functional categories. Many of them are intriguing and unexpected candidates for genes that alter tuberculosis disease progression in humans.



2. We made significant progress in analyzing three of these genes in the course of this work:

mad: the effect of mad on mycobacterial susceptibility revealed unexpected roles of two different TGF-beta superfamily members as immunoregulatory cytokines in Drosophila. This work is important for several reasons. First, it sheds light on the comparative function of TGF-betas in immunity. Nothing was previously known about this in organisms other than mammals. Second, it reveals an unexpected heterogeneity in the function of Drosophila blood cells: this work is the first evidence that some blood cells in the fly inhibit immune responses, as is seen in mammals. This work has been published.



Mef2: we are currently analyzing the function of the transcription factor Mef2 in Drosophila immunity. We have found that Mef2 is required for both immune and metabolic functions in the fly. Moreover, we find that Mef2 activity is a critical determinant of immune-induced wasting in the fly, and we have hints that this function is conserved in humans. As cachexia is a significant driver of human morbidity and mortality in infections, autoimmune disease and cancer, this work has significant translational implications. We are currently working hard to put the finishing touches on this work (we currently expect this to be published within the next 9 months).



SC35: we have strong evidence that SC35 is a previously-unrecognized component of the imd signalling pathway in fly immunity and the TNF signalling pathway in human inflammation. As TNF is a critical driver of pathology in autoimmune disease and is also required in humans for effective immune responses, new regulators of this pathway have significant translational implications.



It should be noted that all three of these genes, and much of the subsequent analysis, depended on the screening funded by BBSRC.
Exploitation Route Our findings will require some academic validation before becoming commercializable, but we can easily envision these genes, or others identified in our screens, as targets for drug therapies against tuberculosis or other infections in humans and animals. By targeting the host rather than the microbe in infections, we may be able to circumvent the problems of drug resistance that bedevil antibiotic discovery. In terms of the three genes we have thoroughly characterized, two have clear translational potential: SC35 as a TNF regulator, and Mef2 as a core regulator of immune-metabolic crosstalk in inflammation, infection and cancer. If these genes can be targeted by drugs, we may be able to inhibit a wide variety of pathologies.
Sectors Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description Our findings have had significant scientific impact; commercial impact is still some time away, as our work is very much basic science. However, our findings of novel regulators and mechanisms in innate immunity and metabolism have drawn significant interest and we are currently exploring follow-up strategies to take this work toward human health.
 
Description A novel role for wnt4 in regulation of insulin signalling and metabolism in vivo.
Amount £276,000 (GBP)
Funding ID 085119 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2009 
End 03/2013
 
Description CASE studentship
Amount £32,000 (GBP)
Funding ID BB/L502169/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 09/2013 
End 09/2017
 
Description Investigator Award
Amount £1,103,343 (GBP)
Funding ID 207467/Z/17/Z 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 02/2018 
End 01/2023
 
Description Physiological integration of TNF- and Interleukin-like signals
Amount £111,000 (GBP)
Organisation Nuffield Foundation 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2009 
End 09/2013
 
Description Project Grant
Amount £289,521 (GBP)
Funding ID BB/L/020122/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 08/2014 
End 09/2017
 
Description Research Grant
Amount £402,320 (GBP)
Funding ID MR/L018802/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 08/2014 
End 08/2017
 
Description Research Grant
Amount £386,210 (GBP)
Funding ID MR/R00997X/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 01/2018 
End 01/2021
 
Description Responsive mode
Amount £423,223 (GBP)
Funding ID BB/P000592/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 05/2017 
End 05/2020
 
Title Infection models in Drosophila melanogaster 
Description We have continued to explore and develop new approaches for the analysis of bacterial pathogenic mechanisms in vivo in the fruit-fly Drosophila melanogaster. This has been detailed in several publications. 
Type Of Material Model of mechanisms or symptoms - non-mammalian in vivo 
Year Produced 2008 
Provided To Others? Yes  
Impact Our work in this regard has enabled us to acquire further funding for additional expansion of these techniques. We have also helped several colleagues adapt these methods to their own biological systems. Finally, it has enabled us to have input into the general problem of using invertebrate model organisms to model human health (for example, I have been asked to consult on an NC3Rs funding call for approaches to severe asthma in nonmammalian model systems). 
 
Title Integration of computational prediction and experimental genetic analysis for identifying biological function 
Description We developed techniques to integrate computational predictions of biological function for transcription factors with experimental functional analysis. This allowed us to identify new physiological functions for two transcription factors (Drosophila Mad and Mef2) as well as to identify a new signaling pathway that regulates immune-metabolic interaction downstream of nutrient signals. 
Type Of Material Data analysis technique 
Year Produced 2013 
Provided To Others? Yes  
Impact We have worked with several other research teams to bring this type of analysis to their biological systems. None of this work has yet been published but manuscripts are in preparation. 
 
Description M abscessus infection in Drosophila 
Organisation Medical Research Council (MRC)
Department MRC Laboratory of Molecular Biology (LMB)
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with the lab of Andres Floto (LMB/University of Cambridge) on genetics of Mycobacterium abscessus infection. We hosted Dr Lucas Boeck from LMB to enable experiments infecting flies with M abscessus as part of this, and will continue ourselves with follow-up experiments as necessary.
Collaborator Contribution They had done significant amounts of abscessus genetics and are now attempting to correlate this with pathogenesis in many systems. We are helping with one aspect of this work.
Impact None yet. Collaboration bridges clinical infectious disease and basic microbiology and immunology.
Start Year 2017